Description

9-Hydroxy-11,15-Dioxo-2,3,18,19-Tetranorprost-5-Ene-1,20-Dioic Acid is a high-purity prostaglandin derivative, a key advanced intermediate in the synthesis of complex bioactive molecules. Its precise chemical structure makes it an indispensable building block for pharmaceutical research and development, offering a reliable foundation for creating novel therapeutic agents. This compound is primarily sought by R&D chemists and process development scientists in the pharmaceutical and fine chemical industries for the production of prostaglandin analogs and other specialized active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of prostaglandin-based drugs and their analogs.
• Biochemical Research: Used as a reference standard or starting material in studies investigating prostaglandin pathways, receptor binding, and metabolic processes.
• Process Chemistry: Serves as a key building block for process development and scale-up of specialty active pharmaceutical ingredients (APIs).
• Fine Chemical Synthesis: Employed in the custom synthesis of complex, high-value molecules for contract research and manufacturing organizations (CROs/CMOs).
• Analytical Standard: Utilized in analytical laboratories for method development, validation, and quality control testing of related compounds.

Basic Information

Product Name	9-Hydroxy-11,15-Dioxo-2,3,18,19-Tetranorprost-5-Ene-1,20-Dioic Acid
CAS No.	70803-92-8
Molecular Formula	C20H26O7
Molecular Weight	378.42 g/mol
Synonyms	9-Hydroxy-11,15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid; 9-Hydroxy-11,15-diketotetranorprosta-5,13-dien-1,20-dioic Acid; 9-Hydroxy-15-oxo-11,16-cyclo-tetranorprosta-5,13-dien-1-oic acid; 9-Hydroxy-11,15-dioxo-2,3,18,19-tetranorprosta-5,13-dien-1,20-dioic acid; Prostaglandin B1 Tetranor Dimer Metabolite; PGB1 Tetranor Dimer; 11,15-Dioxo-9-hydroxy-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid
EINECS	Contact for details

Quality Control

Our 9-Hydroxy-11,15-Dioxo-2,3,18,19-Tetranorprost-5-Ene-1,20-Dioic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation (IR, NMR), to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) with detailed chromatographic data are provided for every shipment, ensuring full traceability and compliance with your internal quality protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is light-sensitive and easily oxidized; for long-term storage, it is recommended to keep the container under an inert atmosphere (e.g., nitrogen or argon) to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.